CAPTRUST FINANCIAL ADVISORS - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 257 filers reported holding HAEMONETICS CORP in Q2 2019. The put-call ratio across all filers is 2.19 and the average weighting 0.1%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2024$270,196
-1.2%
3,266
+1.9%
0.00%0.0%
Q1 2024$273,461
-51.2%
3,204
-51.1%
0.00%
-50.0%
Q4 2023$560,689
-42.2%
6,557
-39.4%
0.00%
-50.0%
Q3 2023$969,435
+27.1%
10,822
+20.8%
0.00%
+33.3%
Q2 2023$762,599
+418.8%
8,957
+298.1%
0.00%
+200.0%
Q2 2022$147,000
-0.7%
2,250
-3.6%
0.00%0.0%
Q1 2022$148,000
+59.1%
2,335
+33.4%
0.00%0.0%
Q4 2021$93,000
-38.8%
1,750
-18.8%
0.00%0.0%
Q3 2021$152,000
+10.9%
2,155
+5.1%
0.00%0.0%
Q2 2021$137,000
-38.6%
2,050
+2.0%
0.00%
-50.0%
Q1 2021$223,000
+1293.8%
2,010
+1388.9%
0.00%
Q4 2020$16,000
+33.3%
1350.0%0.00%
Q3 2020$12,000
+500.0%
135
+440.0%
0.00%
Q2 2020$2,000
-33.3%
250.0%0.00%
Q3 2019$3,0000.0%250.0%0.00%
Q2 2019$3,000250.00%
Other shareholders
HAEMONETICS CORP shareholders Q2 2019
NameSharesValueWeighting ↓
Black Creek Investment Management Inc. 1,014,941$33,077,0003.62%
Camber Capital Management LP 1,202,000$39,173,0003.07%
AMERICAN CAPITAL MANAGEMENT INC 718,380$23,412,0002.76%
Van Berkom & Associates Inc. 1,258,322$41,009,0002.31%
SNYDER CAPITAL MANAGEMENT L P 1,222,547$39,843,0002.07%
KESTREL INVESTMENT MANAGEMENT CORP 441,250$14,380,0001.78%
STONE RUN CAPITAL, LLC 33,740$1,100,0000.80%
HERMES INVESTMENT MANAGEMENT LTD 728,123$23,730,0000.75%
ANCHOR CAPITAL ADVISORS LLC 1,119,060$36,470,0000.73%
Netols Asset Management, Inc. 137,267$4,473,0000.72%
View complete list of HAEMONETICS CORP shareholders